◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

HomeAll stocks0-9 › 4885

Muromachi Chemicals Inc. (4885) Financial History

4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

Basic Materials · Chemicals · DATA UPDATED 2026-08-11

Muromachi Chemicals Inc. (4885) operates in the Chemicals industry and is headquartered in Omuta, Japan. Its market capitalization is roughly JPY 4 billion. In the fiscal year ended 2025-05-31, 4885 reported JPY 6.7B in revenue and JPY 241M in net income.

Muromachi Chemicals Inc. plans, produces, and distributes pharmaceuticals, health foods, and chemicals in Japan.

Interactive charts & full statements →

4885 Revenue & Earnings History — Annual Income Statement

Income statement2025-05-312024-05-312023-05-312022-05-31
Total RevenueJPY 6.7BJPY 6.4BJPY 6.3BJPY 5.7B
Gross ProfitJPY 2.0BJPY 1.9BJPY 1.8BJPY 1.7B
Operating Income (EBIT)JPY 432MJPY 422MJPY 369MJPY 437M
Net IncomeJPY 241MJPY 330MJPY 256MJPY 456M

JPY; JPYM / JPYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

4885 Free Cash Flow History

Cash flow2025-05-312024-05-312023-05-312022-05-31
Dividends Paid(JPY 87M)(JPY 74M)(JPY 71M)(JPY 55M)

JPY; JPYM / JPYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

4885 Balance Sheet History

Balance sheet2025-05-312024-05-312023-05-312022-05-31
Total AssetsJPY 5.3BJPY 5.1BJPY 4.9BJPY 4.8B
Total LiabilitiesJPY 2.8BJPY 2.8BJPY 3.0BJPY 3.1B

JPY; JPYM / JPYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive 4885 viewer.

Other Companies in Chemicals

← 4880All “0-9” companies4886 →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.